It’s a challenge breaking into the U.S. market. Traction is hard. Competition is intense. Companies use VC funding to buy business. Pilots are hard to convert into paying contracts for sustainability (LTCV).
Too many companies falter in the go-to-market phase, exposing themselves to lower valuations, significant financing risks, and suboptimal outcomes. These companies may lack product-market fit, business model fit, localization, proof points, and customer validation. Forty percent of all failed launches are due product-market fit alone.
Then after you jump through all those hoops, further questions and dilemmas arise:
Who pays? The consumer? Insurance? The government? Pharma? It’s hard to follow the money while simultaneously making your business case in the U.S. with the plethora of reimbursement, business model and regulatory paths.
To create paths forward, VentureLab and VenAdvisory bring you a working, collaborative session where we will offer real-world, practical tools, frameworks and tips for commercializing health solutions in U.S. markets. See how you can save 30% more time and money while getting to market.